日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin

更正:I型胶原N端前肽与疑似冠状动脉源性急性胸痛的不良预后相关

Andersen, Thomas; Ueland, Thor; Aukrust, Pål; Nilsen, Dennis W T; Grundt, Heidi; Staines, Harry; Pönitz, Volker; Kontny, Frederic

Correction: Podocan and adverse clinical outcome in patients admitted with suspected acute coronary syndromes

更正:Podocan 与疑似急性冠脉综合征入院患者的不良临床结局

Andersen, Thomas; Ueland, Thor; Aukrust, Pål; Nilsen, Dennis W; Grundt, Heidi; Staines, Harry; Kontny, Frederic

Editorial: Novel and potential biomarkers for prediction of outcome in patients with chronic and acute coronary heart disease, volume II

社论:用于预测慢性及急性冠心病患者预后的新型及潜在生物标志物,第二卷

Nilsen, Dennis W T; Kontny, Frederic; Ten Cate, Hugo

The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease.

蛋白酶激活受体-1 (PAR-1) 抑制对冠状动脉疾病患者内皮相关生物标志物的影响

Nilsen Dennis W T, Røysland Michelle, Ueland Thor, Aukrust Pål, Michelsen Annika E, Staines Harry, Barvik Ståle, Kontny Frederic, Nordrehaug Jan Erik, Bonarjee Vernon V S

Podocan and Adverse Clinical Outcome in Patients Admitted With Suspected Acute Coronary Syndromes

足多卡因与疑似急性冠脉综合征入院患者的不良临床结局

Andersen, Thomas; Ueland, Thor; Aukrust, Pål; Nilsen, Dennis W; Grundt, Heidi; Staines, Harry; Kontny, Frederic

Legumain in Acute Coronary Syndromes: A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) Trial

急性冠脉综合征中应用半胱氨酸蛋白酶:PLATO(血小板抑制与患者预后)试验的子研究

Gregersen, Ida; Michelsen, Annika E; Lunde, Ngoc Nguyen; Åkerblom, Axel; Lakic, Tatevik G; Skjelland, Mona; Ryeng Skagen, Karolina; Becker, Richard C; Lindbäck, Johan; Himmelmann, Anders; Solberg, Rigmor; Johansen, Harald T; James, Stefan K; Siegbahn, Agneta; Storey, Robert F; Kontny, Frederic; Aukrust, Pål; Ueland, Thor; Wallentin, Lars; Halvorsen, Bente

Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54

在欧洲获批的适应症中,替格瑞洛治疗既往有心肌梗死病史患者的疗效和安全性:来自 PEGASUS-TIMI 54 研究的启示

Dellborg, Mikael; Bonaca, Marc P; Storey, Robert F; Steg, P Gabriel; Im, Kyung A; Cohen, Marc; Bhatt, Deepak L; Oude Ophuis, Ton; Budaj, Andrezej; Hamm, Christian; Spinar, Jindrich; Kiss, Robert G; Lopez-Sendon, José; Kamensky, Gabriel; Van de Werf, Frans; Ardissino, Diego; Kontny, Frederic; Montalescot, Gilles; Johanson, Per; Bengtsson, Olof; Himmelmann, Anders; Braunwald, Eugene; Sabatine, Marc S

Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y(12) Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial

糖尿病和慢性肾脏病对急性冠脉综合征患者心血管结局和血小板P2Y(12)受体拮抗剂效应的影响:来自PLATO试验的启示

Franchi, Francesco; James, Stefan K; Ghukasyan Lakic, Tatevik; Budaj, Andrzej J; Cornel, Jan H; Katus, Hugo A; Keltai, Matyas; Kontny, Frederic; Lewis, Basil S; Storey, Robert F; Himmelmann, Anders; Wallentin, Lars; Angiolillo, Dominick J

Effects of telmisartan on office and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care

替米沙坦对诊室血压和24小时动态血压的影响:一项在基层医疗机构接受治疗的高血压患者的观察性研究

Kontny, Frederic; Risanger, Terje; Bye, Arne; Arnesen, Øyvind; Johansen, Odd Erik